ASX - By Stock
|
RHT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hepa82
|
21 |
5.5K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
21
|
5.5K
|
3
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hepa82
|
21 |
5.5K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
5.5K
|
3
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hepa82
|
21 |
5.5K |
8 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
5.5K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
hepa82
|
554 |
201K |
8 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
554
|
201K
|
8
|
|
ASX - By Stock
|
VMM |
Re:
Ann: StepOut Drilling Multiplies Cupim South High-Grade Footprint
|
|
hepa82
|
52 |
16K |
5 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
52
|
16K
|
5
|
|
ASX - By Stock
|
VMM |
Re:
Ann: StepOut Drilling Multiplies Cupim South High-Grade Footprint
|
|
hepa82
|
52 |
16K |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
52
|
16K
|
3
|
|
ASX - By Stock
|
VMM |
Re:
Ann: StepOut Drilling Multiplies Cupim South High-Grade Footprint
|
|
hepa82
|
52 |
16K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
52
|
16K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
hepa82
|
230 |
109K |
23 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
230
|
109K
|
23
|
|
ASX - By Stock
|
APX |
Re:
Ann: 2024 AGM - CEO Address & Presentation
|
|
hepa82
|
196 |
50K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
196
|
50K
|
2
|
|
ASX - By Stock
|
APX |
Re:
Appen launches solution for enterprises to customize
|
|
hepa82
|
29 |
16K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
29
|
16K
|
0
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hepa82
|
9 |
4.4K |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
9
|
4.4K
|
5
|
|
ASX - By Stock
|
APX |
Re:
Appen launches solution for enterprises to customize
|
|
hepa82
|
29 |
16K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
29
|
16K
|
0
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hepa82
|
9 |
4.4K |
6 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
9
|
4.4K
|
6
|
|
ASX - By Stock
|
APX |
Re:
Appen launches solution for enterprises to customize
|
|
hepa82
|
29 |
16K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
29
|
16K
|
1
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: 2D Seismic Identifies Multiple Prospects in Dande Formation
|
|
hepa82
|
147 |
52K |
3 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
147
|
52K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: 2D Seismic Identifies Multiple Prospects in Dande Formation
|
|
hepa82
|
147 |
52K |
6 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
147
|
52K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: 2D Seismic Identifies Multiple Prospects in Dande Formation
|
|
hepa82
|
147 |
52K |
3 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
147
|
52K
|
3
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
hepa82
|
22K |
7.6M |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
22K
|
7.6M
|
4
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
hepa82
|
22K |
7.6M |
7 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
22K
|
7.6M
|
7
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
hepa82
|
22K |
7.6M |
7 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
22K
|
7.6M
|
7
|
|
ASX - By Stock
|
APX |
Re:
Appen launches solution for enterprises to customize
|
|
hepa82
|
29 |
16K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
hepa82
|
48 |
16K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
16K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
hepa82
|
48 |
16K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
16K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
hepa82
|
48 |
16K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
16K
|
0
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
6 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
48
|
16K
|
6
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
48
|
16K
|
6
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
48
|
16K
|
8
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
hepa82
|
49 |
16K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
hepa82
|
49 |
16K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
hepa82
|
49 |
16K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
48
|
16K
|
4
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
48
|
16K
|
4
|
|
ASX - By Stock
|
APX |
Re:
APX Charts
|
|
hepa82
|
1.5K |
527K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.5K
|
527K
|
0
|
|
ASX - By Stock
|
APX |
Re:
APX Charts
|
|
hepa82
|
1.5K |
527K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.5K
|
527K
|
1
|
|
ASX - By Stock
|
G1A |
Re:
Ann: Appointment of Voluntary Administrators
|
|
hepa82
|
57 |
47K |
9 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
57
|
47K
|
9
|
|
ASX - By Stock
|
TNC |
Re:
Ann: TNC announces $5M institutional placement
|
|
hepa82
|
60 |
27K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
60
|
27K
|
2
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
48
|
16K
|
6
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Trading Halt
|
|
hepa82
|
48 |
16K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
48
|
16K
|
4
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Acquisition of TrialsWest Group
|
|
hepa82
|
2 |
1.2K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
2
|
1.2K
|
8
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
hepa82
|
49 |
16K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
49
|
16K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
hepa82
|
49 |
16K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
RHT |
Re:
Ann: Collaboration with Micron, Inc.
|
|
hepa82
|
11 |
2.7K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
11
|
2.7K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl receives non-binding offer for its Opin business
|
|
hepa82
|
14 |
4.5K |
2 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
14
|
4.5K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl receives non-binding offer for its Opin business
|
|
hepa82
|
14 |
4.5K |
3 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
14
|
4.5K
|
3
|
|
ASX - By Stock
|
AMD |
Re:
AMD General Discussion
|
|
hepa82
|
584 |
273K |
2 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
584
|
273K
|
2
|
|
ASX - By Stock
|
AMD |
Re:
AMD General Discussion
|
|
hepa82
|
584 |
273K |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
584
|
273K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to Present at Euroz Hartley Institutional Conference
|
|
hepa82
|
37 |
10K |
12 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
37
|
10K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
hepa82
|
247 |
81K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
81K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
hepa82
|
247 |
81K |
21 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
81K
|
21
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
hepa82
|
247 |
81K |
11 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
81K
|
11
|
|